Table 1 Characteristics of the 75 patients whose metabolome abundances are described. LOS = Length of Stay; APACHE II = Acute Physiology and Chronic Health Evaluation Score; SOFA = Sequentional Organ Failure Assessment; RRT = Renal Replacement Therapy; NMBA = Neuromuscular Blockade administration. Data are mean (95% confidence intervals), except for # indicating median with range.

From: The metabolic effects of intermittent versus continuous feeding in critically ill patients

 

Intermittent Feeding (n = 40)

Continuous Feeding (n = 35)

Age, y

55(50.0–60.0)

61 (55–67)

Male, No. (%) ¥

11 (27.5)

9 (25.7)

LOS prior to ICU admission, d #

0.0 (0–15)

0.0 (0–13)

Period ventilated, d #

11 (2–48)

8 (2–41)

ICU LOS, d#

16 (3–93)

17 (3–52)

Hospital LOS, d#

27 (4–183)

32 (4–102)

APACHE II score

21 (19–24)

20 (17–22)

SOFA score on admission

10 (9–11)

11 (10–12)

ICU survival, No. (%)

28 (70)

29 (83)

Hospital survival, No. (%)

21 (52.5)

28 (80)

RRT, No. (%)

16 (40)

12 (34)

NMBA use, d#

0 (0–8)

1 (0–6)

Hydrocortisone dose, mg total by day 10

0 (0–2700)

0 (0–3200)

Gastro-protection, d#

9 (0–11)

10 (0–11)

Vasopressors support, d#

4 (0–11)

5 (0–22)

Sedation use, d#

7 (2–11)

6 (0–11)

Propofol dose by day 10, g

21.1 (15.2–27.1)

23.0 (16.4–29.5)

Admission diagnosis, No. (%)

 Sepsis

13 (32.5)

14 (40)

 Cardiogenic shock

9 (22.5)

8 (22.9)

 Trauma

5 (12.5)

7 (20.0)

 Respiratory failure

5 (12.5)

1 (2.9)

 Intracranial haemorrhage

2 (5.0)

1 (2.9)

 Acute liver failure

2 (5.0)

2 (5.7)

 Acute kidney Injury

2 (5.0)

1 (2.9)

 Drug overdose

1 (2.5)

0 (0.0)

 Emergency surgery

1 (2.5)

1 (2.9)

 Cerebrovascular accident

0 (0.0)

0 (0.0)

Comorbidities, No. (%)

 Hypertension

9 (22.5)

4 (11.4)

 Chronic respiratory diseases

9 (22.5)

11 (31.4)

 Diabetes Mellitus

8(20.0)

7 (20.0)

 Ischemic heart disease

8 (20.0)

10 (28.6)

 Psychiatric diseases

6 (15.0)

5(14.3)

 Renal impairment

2 (5.0)

5 (14.3)

 Obesity

4 (10.0)

1 (2.9)

 Liver cirrhosis

3 (7.5)

3 (8.6)

 Haem-oncological disease

3 (7.5)

1 (2.9)

 Thyroid disease

2 (5.0)

0 (0.0)

 Crohn’s disease

0 (0.0)

1 (2.9)

 Previous CVA

1 (2.5)

1 (2.9)

 Chronic Pancreatitis

1 (2.5)

0 (0.0)